ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marc A. Ruel
Frank W. Sellke
William E. Cohn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruel, M. A.
Right arrow Articles by Cohn, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruel, M. A.
Right arrow Articles by Cohn, W. E.
Related Collections
Right arrow Myocardial infarction

Ann Thorac Surg 2003;75:1443-1449
© 2003 The Society of Thoracic Surgeons


Original article: cardiovascular

Endogenous myocardial angiogenesis and revascularization using a gastric submucosal patch

Marc A. Ruel, MD, MPha,b, Frank W. Sellke, MDb, Cesario Bianchi, MD, PhDb, Tanveer A. Khan, MDb, Renato Faro, PhDb, Jian-Ping Zhang, MDb, William E. Cohn, MDa,b*

a Center for Minimally Invasive Surgery, Harvard Medical School, Boston, MA, USA
b Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, Boston, MA, USA

Accepted for publication October 24, 2002.

* Address reprint requests to Dr Cohn, Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 2A, Boston, MA 02215, USA
e-mail: wcohn{at}caregroup.harvard.edu

BACKGROUND: The gastrointestinal submucosa physiologically produces angiogenic proteins. We examined whether these properties could lead to endogenous myocardial angiogenesis in a swine model of chronic ischemia.

METHODS: Fifteen Yorkshire swine underwent ameroid constrictor placement around the circumflex artery and either lateral epicardial abrasion, creation of a gastroepiploic artery (GEA) based gastric patch, mucosal avulsion, transdiaphragmatic transfer, and apposition of the patch against the circumflex myocardial territory (number = 8; test animals), or lateral epicardial abrasion alone (number = 7; controls). Seven weeks later, lateral myocardial perfusion, endothelial cell density, and expression of VEGFR-1 and VE-cadherin were determined using isotope-labeled microsphere assays, immunohistochemistry, and immunoblotting, respectively.

RESULTS: Microsphere assays showed equivalent lateral/anterior myocardial perfusion indices at rest (1.10 ± 0.49 vs 0.95 ± 0.23, test vs control animals; p = 0.54), but higher perfusion in test animals versus controls during pacing (1.05 ± 0.29 vs 0.69 ± 0.09, test vs controls; p = 0.02). Increased myocardial endothelial cell density (42.6 ± 8.5 vs 26.1 ± 11.6 cells per 3850 µm2, test vs controls; p = 0.02) and expression of VE-cadherin (3.10 ± 0.60-fold change, test vs controls; p = 0.001) were also observed in the lateral territory of test animals versus controls. Reconstitution of the proximally occluded circumflex artery from patch collaterals was demonstrated on gastroepiploic arteriography in a subset of test animals.

CONCLUSIONS: This model results in an angiogenic process of significantly greater magnitude than that resulting from chronic myocardial ischemia alone, without the need for exogenous angiogenic agents.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Takaba, C. Jiang, S. Nemoto, Y. Saji, T. Ikeda, S. Urayama, T. Azuma, A. Hokugo, S. Tsutsumi, Y. Tabata, et al.
A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: Evolving concept of biologic coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 891 - 899.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Kanamori, G. Watanabe, T. Yasuda, H. Nagamine, H. Kamiya, and Y. Koshida
Hybrid Surgical Angiogenesis: Omentopexy Can Enhance Myocardial Angiogenesis Induced by Cell Therapy
Ann. Thorac. Surg., January 1, 2006; 81(1): 160 - 167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Voisine, J. Li, C. Bianchi, T. A. Khan, M. Ruel, S.-H. Xu, J. Feng, A. Rosinberg, T. Malik, Y. Nakai, et al.
Effects of L-Arginine on Fibroblast Growth Factor 2-Induced Angiogenesis in a Model of Endothelial Dysfunction
Circulation, August 30, 2005; 112(9_suppl): I-202 - I-207.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Voisine, C. Bianchi, T. A. Khan, M. Ruel, S.-H. Xu, J. Feng, J. Li, T. Malik, A. Rosinberg, and F. W. Sellke
Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of L-arginine in a porcine model of endothelial dysfunction
J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1414 - 1420.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ruel, G. F. Wu, T. A. Khan, P. Voisine, C. Bianchi, J. Li, J. Li, R. J. Laham, and F. W. Sellke
Inhibition of the Cardiac Angiogenic Response to Surgical FGF-2 Therapy in a Swine Endothelial Dysfunction Model
Circulation, September 9, 2003; 108(90101): II-335 - 340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.